347 related articles for article (PubMed ID: 22829240)
1. Treatment of liver metastases in patients with digestive neuroendocrine tumors.
Rossi RE; Massironi S; Spampatti MP; Conte D; Ciafardini C; Cavalcoli F; Peracchi M
J Gastrointest Surg; 2012 Oct; 16(10):1981-92. PubMed ID: 22829240
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy--A literature review.
Berardi R; Rinaldi S; Torniai M; Morgese F; Partelli S; Caramanti M; Onofri A; Polenta V; Pagliaretta S; Falconi M; Cascinu S
Crit Rev Oncol Hematol; 2016 Feb; 98():264-74. PubMed ID: 26643525
[TBL] [Abstract][Full Text] [Related]
3. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.
Alagusundaramoorthy SS; Gedaly R
World J Gastroenterol; 2014 Oct; 20(39):14348-58. PubMed ID: 25339822
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for PNET liver metastases: a systematic review.
Nigri G; Petrucciani N; Debs T; Mangogna LM; Crovetto A; Moschetta G; Persechino R; Aurello P; Ramacciato G
World J Surg Oncol; 2018 Jul; 16(1):142. PubMed ID: 30007406
[TBL] [Abstract][Full Text] [Related]
5. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs.
de Baere T; Deschamps F; Tselikas L; Ducreux M; Planchard D; Pearson E; Berdelou A; Leboulleux S; Elias D; Baudin E
Eur J Endocrinol; 2015 Apr; 172(4):R151-66. PubMed ID: 25385817
[TBL] [Abstract][Full Text] [Related]
6. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
7. Management of patients with hepatic metastases from neuroendocrine tumors.
Clift AK; Frilling A
Ann Saudi Med; 2014; 34(4):279-90. PubMed ID: 25811199
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Auernhammer CJ; Göke B
Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
[TBL] [Abstract][Full Text] [Related]
9. Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver.
Keutgen XM; Schadde E; Pommier RF; Halfdanarson TR; Howe JR; Kebebew E
Semin Oncol; 2018 Aug; 45(4):232-235. PubMed ID: 30318110
[TBL] [Abstract][Full Text] [Related]
10. Management of advanced neuroendocrine tumors with hepatic metastasis.
Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
[TBL] [Abstract][Full Text] [Related]
11. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
12. Multimodal management of neuroendocrine liver metastases.
Frilling A; Sotiropoulos GC; Li J; Kornasiewicz O; Plöckinger U
HPB (Oxford); 2010 Aug; 12(6):361-79. PubMed ID: 20662787
[TBL] [Abstract][Full Text] [Related]
13. Therapy for metastatic pancreatic neuroendocrine tumors.
Rossi RE; Massironi S; Conte D; Peracchi M
Ann Transl Med; 2014 Jan; 2(1):8. PubMed ID: 25332984
[TBL] [Abstract][Full Text] [Related]
14. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
15. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
16. Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.
Mayo SC; Herman JM; Cosgrove D; Bhagat N; Kamel I; Geschwind JF; Pawlik TM
J Am Coll Surg; 2013 Jan; 216(1):123-34. PubMed ID: 23063263
[TBL] [Abstract][Full Text] [Related]
17. Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
Mujica-Mota R; Varley-Campbell J; Tikhonova I; Cooper C; Griffin E; Haasova M; Peters J; Lucherini S; Talens-Bou J; Long L; Sherriff D; Napier M; Ramage J; Hoyle M
Health Technol Assess; 2018 Sep; 22(49):1-326. PubMed ID: 30209002
[TBL] [Abstract][Full Text] [Related]
18. New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors.
Scoville SD; Cloyd JM; Pawlik TM
Expert Opin Pharmacother; 2020 Feb; 21(2):183-191. PubMed ID: 31760823
[No Abstract] [Full Text] [Related]
19. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.
Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M
Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289
[TBL] [Abstract][Full Text] [Related]
20. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.
Kennedy A; Bester L; Salem R; Sharma RA; Parks RW; Ruszniewski P;
HPB (Oxford); 2015 Jan; 17(1):29-37. PubMed ID: 25186181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
